Evidence map›Paper›PMID 33103541›Full record

ArticleJournal of the American Heart Association2020

Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Nobuhiro Yaoita, Kimio Satoh, Taijyu Satoh, Toru Shimizu, Sakae Saito, Koichiro Sugimura, Shunsuke Tatebe, Saori Yamamoto, Tatsuo Aoki, Nobuhiro Kikuchi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Rare variants inERJ open research · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.Journal of the American Heart Association · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Nobuhiro YaoitaDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Kimio SatohDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Taijyu SatohDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Toru ShimizuDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Sakae SaitoDepartment of Integrative Genomics Tohoku Medical Megabank Organization Tohoku University Sendai Japan.
Koichiro SugimuraDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Shunsuke TatebeDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Saori YamamotoDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Tatsuo AokiDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Nobuhiro KikuchiDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Ryo KurosawaDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Satoshi MiyataDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Masao NagasakiDepartment of Integrative Genomics Tohoku Medical Megabank Organization Tohoku University Sendai Japan.
Jun YasudaDepartment of Integrative Genomics Tohoku Medical Megabank Organization Tohoku University Sendai Japan.
Hiroaki ShimokawaDepartment of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Although chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (APE) share some clinical manifestations, a limited proportion of patients with CTEPH have a history of APE. Moreover, in histopathologic studies, it has been revealed that pulmonary vasculature lesions similar to pulmonary arterial hypertension existed in patients with CTEPH. Thus, it remains unknown whether these 3 disorders also share genetic backgrounds. Methods and Results Whole exome screening was performed with DNA isolated from 51 unrelated patients with CTEPH of Japanese ancestry. The frequency of genetic variants associated with pulmonary arterial hypertension or APE in patients with CTEPH was compared with those in the integrative Japanese Genome Variation Database 3.5KJPN. Whole exome screening analysis showed 17 049 nonsynonymous variants in patients with CTEPH. Although we found 6 nonsynonymous variants that are associated with APE in patients with CTEPH, there was no nonsynonymous variant associated with pulmonary arterial hypertension. Patients with CTEPH with a history of APE had nonsynonymous variants of

Indexed as

Acute DiseaseAgedAged, 80 and overAsian PeopleCarboxypeptidase B2Chronic DiseaseExome SequencingFactor VFemaleGene FrequencyGenetic VariationHumansHypertension, PulmonaryJapanMaleMiddle AgedCarboxypeptidase B2CPB2 protein, humanFactor VTHBD protein, humanThrombomodulinchronic thromboembolic pulmonary hypertensiongene variantspulmonary hypertension

Identifiers

PMID33103541
PMCPMC7763425
OpenAlexW3094463747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.